Dihexa is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is researched primarily for enhanced synaptogenesis, improved cognitive function, memory enhancement, neuroprotection, increased dendritic spine density. Millions of times more potent than BDNF at growing new synapses â the most powerful synaptogenic compound identified. The tradeoff is a legitimate concern about cancer risk through the HGF/c-Met pathway. It belongs to the Synaptogenic neuropeptide, HGF/c-Met pathway agonist category of compounds.
What Is Dihexa?
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a Synaptogenic neuropeptide, HGF/c-Met pathway agonist. Synthetic derivation of Angiotensin IV with enhanced blood-brain barrier penetration.
Millions of times more potent than BDNF at growing new synapses â the most powerful synaptogenic compound identified. The tradeoff is a legitimate concern about cancer risk through the HGF/c-Met pathway. It has attracted significant research interest for its potential effects on enhanced synaptogenesis, improved cognitive function, memory enhancement, neuroprotection, increased dendritic spine density.
How Does Dihexa Produce These Benefits?
Potentiates hepatocyte growth factor (HGF) and its receptor c-Met, driving synaptogenesis (new synapse formation). Preclinical data shows it is millions of times more potent than BDNF at stimulating synapse growth. Also reduces neuroinflammation via NF-ÎșB pathway suppression and protects neurons against oxidative damage.
This multi-pathway activity is why Dihexa shows potential across several different applications rather than being limited to a single use case.
Can Dihexa Help With Enhanced Synaptogenesis?
Research suggests Dihexa may support enhanced synaptogenesis through its synaptogenic neuropeptide, hgf/c-met pathway agonist activity. Rat studies show reversal of Alzheimer's-type cognitive dysfunction, outperforming the prescription drug donepezil (Aricept). Increased synaptic density and spine numbers in cognitively impaired models. No human clinical trials â preclinical only.
Protocols targeting enhanced synaptogenesis typically use 10-40 mg daily administered once daily for 8-12 weeks.
Can Dihexa Help With Improved Cognitive Function?
Research suggests Dihexa may support improved cognitive function through its synaptogenic neuropeptide, hgf/c-met pathway agonist activity. Rat studies show reversal of Alzheimer's-type cognitive dysfunction, outperforming the prescription drug donepezil (Aricept). Increased synaptic density and spine numbers in cognitively impaired models. No human clinical trials â preclinical only.
Protocols targeting improved cognitive function typically use 10-40 mg daily administered once daily for 8-12 weeks.
Can Dihexa Help With Memory Enhancement?
Research suggests Dihexa may support memory enhancement through its synaptogenic neuropeptide, hgf/c-met pathway agonist activity. Rat studies show reversal of Alzheimer's-type cognitive dysfunction, outperforming the prescription drug donepezil (Aricept). Increased synaptic density and spine numbers in cognitively impaired models. No human clinical trials â preclinical only.
Protocols targeting memory enhancement typically use 10-40 mg daily administered once daily for 8-12 weeks.
Can Dihexa Help With Neuroprotection?
Research suggests Dihexa may support neuroprotection through its synaptogenic neuropeptide, hgf/c-met pathway agonist activity. Rat studies show reversal of Alzheimer's-type cognitive dysfunction, outperforming the prescription drug donepezil (Aricept). Increased synaptic density and spine numbers in cognitively impaired models. No human clinical trials â preclinical only.
Protocols targeting neuroprotection typically use 10-40 mg daily administered once daily for 8-12 weeks.
Can Dihexa Help With Increased Dendritic Spine Density?
Research suggests Dihexa may support increased dendritic spine density through its synaptogenic neuropeptide, hgf/c-met pathway agonist activity. Rat studies show reversal of Alzheimer's-type cognitive dysfunction, outperforming the prescription drug donepezil (Aricept). Increased synaptic density and spine numbers in cognitively impaired models. No human clinical trials â preclinical only.
Protocols targeting increased dendritic spine density typically use 10-40 mg daily administered once daily for 8-12 weeks.
Can Stacking Enhance Dihexa Benefits?
Complements Cerebrolysin (neurotrophic factors) and Semax (BDNF) for multi-pathway neuroprotection.
See our Dihexa stacking guide for detailed combination protocols.
What Is the Bottom Line on Dihexa Benefits?
Dihexa is researched for enhanced synaptogenesis, improved cognitive function, memory enhancement, neuroprotection, increased dendritic spine density. The evidence base includes: Rat studies show reversal of Alzheimer's-type cognitive dysfunction, outperforming the prescription drug donepezil (Aricept). Increased synaptic density and spine numbers in cognitively impaired models. No human clinical trials â preclinical only.
Dihexa is not fda-approved. investigational compound. research context only. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
Dihexa : The Potent Nootropic Peptide Explained
Related Reading
- Dihexa Dosage Guide
- Dihexa Side Effects
- Dihexa Stacking Guide
- Dihexa Cycle Guide
- Dihexa Research
- Cerebrolysin Complete Guide
Calculate Your Dihexa Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Dihexa.
Open Calculator →Research-Grade Sourcing
If you're going to research Dihexa, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Dihexa?
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a Synaptogenic neuropeptide, HGF/c-Met pathway agonist. Synthetic derivation of Angiotensin IV with enhanced blood-brain barrier penetration. It is researched for enhanced synaptogenesis, improved cognitive function, memory enhancement, neuroprotection, increased dendritic spine density.
What is the recommended Dihexa dosage?
Common dosages: 10-40 mg daily administered once daily via oral (research protocols). Cycle length: 8-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of Dihexa?
Significant concern about potential cancer risk through HGF/c-Met pathway activation, which is involved in tumor progression. Could theoretically promote maladaptive neural wiring or tumorigenesis. No human clinical safety data available.
Is Dihexa safe?
Dihexa has shown a preliminary safety profile in research. Not FDA-approved. Investigational compound. Research context only. All research should follow appropriate safety protocols.